11 min read
Monthly FDA Guidance and Regulatory News Review - June 2026
This June 2026 regulatory update focuses on advancing innovative drug development through updated guidance on...
Meet Veristat at PHUSE US Connect 2025
Increase the success of your clinical trial by meeting with Veristat at PHUSE US Connect 2025, taking place March 16–19, at the Renaissance Orlando at SeaWorld in Florida. This premier event showcases cutting-edge presentations, workshops, and interactive sessions on data standards, regulatory compliance, statistical analysis, and emerging technologies.
Visit us at our Booth to learn how Veristat’s biometrics expertise aligns perfectly with PHUSE’s focus on innovation and collaboration to get study results faster. From precise data analysis and seamless standardization to regulatory submissions and adaptive trial designs, we help sponsors overcome their most complex challenges.
At PHUSE, where thought leaders gather to shape the future of clinical data science, Veristat brings a proven track record in advancing therapies for rare and ultra-rare diseases. We’re here to accelerate your clinical development journey and ensure your study’s success
Veristat Attendees:
Mark McBride, VP, Biostatistics Consulting
AJ Mills, Global VP, Commercial
Schedule a Meeting:
Arrange a one-on-one meeting with one of our experts by completing the form on the right side of this page. Discover how Veristat can assist you in accelerating your clinical trial or regulatory submission towards a successful outcome.
Learn more about the conference
2 min read
FDA Prior Knowledge Guidance: A New Framework for Natural History Evidence
Jul 2, 2026 Veristat Blog
June 22, 2026
What the FDA's prior knowledge guidance means for natural history evidence and shared datasets
On June 2,...